Loading...
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles, and patient risk factors significantly influence CINV. The use of a combination of a 5-hydroxytryptamine-...
Saved in:
Published in: | Drug Des Devel Ther |
---|---|
Main Author: | |
Format: | Artigo |
Language: | Inglês |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4277122/ https://ncbi.nlm.nih.gov/pubmed/25552904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|